#Biogen #alzheimers #yahoofinance
Mizuho Americas Senior Biotech Analyst Salim Syed joins Yahoo Finance Live anchors Julie Hyman and Brad Smith to discuss encouraging Phase 3 data from Biogen’s Alzheimer’s treatment lecanemab, how many sales the drug could generate, and what this means for the pharmaceutical industry.
Don't Miss: Valley of Hype: The Culture That Built Elizabeth Holmes
WATCH HERE:
[ Ссылка ]
Subscribe to Yahoo Finance: [ Ссылка ]
About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced charting, and more.
To learn more about Yahoo Finance Plus please visit: [ Ссылка ]
Connect with Yahoo Finance:
Get the latest news: [ Ссылка ]
Find Yahoo Finance on Facebook: [ Ссылка ]
Follow Yahoo Finance on Twitter: [ Ссылка ]
Follow Yahoo Finance on Instagram: [ Ссылка ]
Follow Yahoo Finance Premium on Twitter: [ Ссылка ]
